These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36436752)

  • 1. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Morden E; Rousseau P; Arendse J; Bam JL; Boloko L; Cloete K; Cohen C; Chetty N; Dane P; Heekes A; Hsiao NY; Hunter M; Hussey H; Jacobs T; Jassat W; Kariem S; Kassanjee R; Laenen I; Roux SL; Lessells R; Mahomed H; Maughan D; Meintjes G; Mendelson M; Mnguni A; Moodley M; Murie K; Naude J; Ntusi NAB; Paleker M; Parker A; Pienaar D; Preiser W; Prozesky H; Raubenheimer P; Rossouw L; Schrueder N; Smith B; Smith M; Solomon W; Symons G; Taljaard J; Wasserman S; Wilkinson RJ; Wolmarans M; Wolter N; Boulle A
    Int J Infect Dis; 2023 Feb; 127():63-68. PubMed ID: 36436752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Morden E; Rosseau P; Arendse J; Bam JL; Boloko L; Cloete K; Cohen C; Chetty N; Dane P; Heekes A; Hsiao NY; Hunter M; Hussey H; Jacobs T; Jassat W; Kariem S; Kassanjee R; Laenen I; Le Roux S; Lessells R; Mahomed H; Maughan D; Meintjes G; Mendelson M; Mnguni A; Moodley M; Murie K; Naude J; Ntusi NAB; Paleker M; Parker A; Pienaar D; Preiser W; Prozesky H; Raubenheimer P; Rossouw L; Schrueder N; Smith B; Smith M; Solomon W; Symons G; Taljaard J; Wasserman S; Wilkinson RJ; Wolmarans M; Wolter N; Boulle A
    medRxiv; 2022 Jul; ():. PubMed ID: 35794899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Kassanjee R; Rousseau P; Morden E; Johnson L; Solomon W; Hsiao NY; Hussey H; Meintjes G; Paleker M; Jacobs T; Raubenheimer P; Heekes A; Dane P; Bam JL; Smith M; Preiser W; Pienaar D; Mendelson M; Naude J; Schrueder N; Mnguni A; Le Roux S; Murie K; Prozesky H; Mahomed H; Rossouw L; Wasserman S; Maughan D; Boloko L; Smith B; Taljaard J; Symons G; Ntusi NAB; Parker A; Wolter N; Jassat W; Cohen C; Lessells R; Wilkinson RJ; Arendse J; Kariem S; Moodley M; Wolmarans M; Cloete K; Boulle A;
    Trop Med Int Health; 2022 Jun; 27(6):564-573. PubMed ID: 35411997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Kassanjee R; Rosseau P; Morden E; Johnson L; Solomon W; Hsiao NY; Hussey H; Meintjes G; Paleker M; Jacobs T; Raubenheimer P; Heekes A; Dane P; Bam JL; Smith M; Preiser W; Pienaar D; Mendelson M; Naude J; Schrueder N; Mnguni A; Roux SL; Murie K; Prozesky H; Mahomed H; Rossouw L; Wasserman S; Maughan D; Boloko L; Smith B; Taljaard J; Symons G; Ntusi N; Parker A; Wolter N; Jassat W; Cohen C; Lessells R; Wilkinson RJ; Arendse J; Kariem S; Moodley M; Vallabhjee K; Wolmarans M; Cloete K; Boulle A
    medRxiv; 2022 Jan; ():. PubMed ID: 35043121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa.
    Jassat W; Abdool Karim SS; Ozougwu L; Welch R; Mudara C; Masha M; Rousseau P; Wolmarans M; Selikow A; Govender N; Walaza S; von Gottberg A; Wolter N; Terrence Pisa P; Sanne I; Govender S; Blumberg L; Cohen C; Groome MJ;
    Clin Infect Dis; 2023 Apr; 76(8):1468-1475. PubMed ID: 36453094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Blumberg L; Welch R; Izu A; Mutevedzi PC
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
    Hussey H; Davies MA; Heekes A; Williamson C; Valley-Omar Z; Hardie D; Korsman S; Doolabh D; Preiser W; Maponga T; Iranzadeh A; Wasserman S; Boloko L; Symons G; Raubenheimer P; Parker A; Schrueder N; Solomon W; Rousseau P; Wolter N; Jassat W; Cohen C; Lessells R; Wilkinson RJ; Boulle A; Hsiao NY
    Int J Infect Dis; 2022 May; 118():150-154. PubMed ID: 35235826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
    Johnson R; Mangwana N; Sharma JR; Muller CJF; Malemela K; Mashau F; Dias S; Ramharack P; Kinnear C; Glanzmann B; Viraragavan A; Louw J; Surujlal-Naicker S; Nkambule S; Webster C; Mdhluli M; Gray G; Mathee A; Preiser W; Vorster A; Dalvie S; Street R
    J Infect Dis; 2022 Oct; 226(8):1418-1427. PubMed ID: 36017801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome MJ; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Subramoney K; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Nat Commun; 2022 Oct; 13(1):5860. PubMed ID: 36195617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.
    Sun K; Tempia S; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; Carrim M; Martinson NA; Kahn K; Lebina L; du Toit JD; Mkhencele T; Viboud C; Cohen C;
    Nat Commun; 2023 Jan; 14(1):246. PubMed ID: 36646700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022.
    Chiwandire N; Jassat W; Groome M; Kufa T; Walaza S; Wolter N; von Gottberg A; Zar HJ; Reubenson G; Tempia S; Ebonwu J; Govender N; Ntshoe G; Shonhiwa AM; Blumberg L; Cohen C
    J Pediatric Infect Dis Soc; 2023 Apr; 12(3):128-134. PubMed ID: 36648247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
    Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
    Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.
    Sun K; Tempia S; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; Carrim M; Martinson NA; Kahn K; Lebina L; du Toit JD; Mkhencele T; Viboud C; Cohen C;
    medRxiv; 2022 Aug; ():. PubMed ID: 36032973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Abdullah F; Myers J; Basu D; Tintinger G; Ueckermann V; Mathebula M; Ramlall R; Spoor S; de Villiers T; Van der Walt Z; Cloete J; Soma-Pillay P; Rheeder P; Paruk F; Engelbrecht A; Lalloo V; Myburg M; Kistan J; van Hougenhouck-Tulleken W; Boswell MT; Gray G; Welch R; Blumberg L; Jassat W
    Int J Infect Dis; 2022 Mar; 116():38-42. PubMed ID: 34971823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
    Torres C; Nabaes Jodar M; Acuña D; Montaño RMZ; Culasso ACA; Amadio AF; Aulicino P; Ceballos S; Cacciabue M; Debat H; Dus Santos MJ; Eberhardt MF; Espul C; Fay F; Fernández MA; Fernández F; Muñoz JMF; Ferrini F; Gallego F; Giri AA; Cerri A; Bolatti E; Gismondi MI; Goya S; Gramundi I; Irazoqui JM; König GA; Leiva V; Lucero H; Marquez N; Nardi C; Ortiz B; Pianciola L; Pintos CB; Puebla AF; Rastellini CV; Rojas AE; Sfalcin J; Suárez A; Tittarelli E; Toro R; Villanova GV; Ziehm MC; Zimmermann MC; Zunino S; Proyecto Pais Working Group ; Valinotto L; Viegas M
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
    Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
    Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.
    Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY
    Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory-Confirmed COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance - COVID-19-Associated Hospitalization Surveillance Network, 14 States, June 20, 2021-May 31, 2022.
    Havers FP; Patel K; Whitaker M; Milucky J; Reingold A; Armistead I; Meek J; Anderson EJ; Weigel A; Reeg L; Seys S; Ropp SL; Spina N; Felsen CB; Moran NE; Sutton M; Talbot HK; George A; Taylor CA;
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(34):1085-1091. PubMed ID: 36006841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.